ICH post AVM rupture - Nursing Case Study

Pathophysiology

• Primary mechanism: Arteriovenous malformation (AVM) rupture leads to direct hemorrhage into brain tissue as high-pressure arterial blood bypasses capillaries, resulting in an intracerebral hemorrhage (ICH) that disrupts neuronal integrity and function.

• Secondary mechanism: The sudden increase in intracranial pressure (ICP) due to the expanding hematoma exerts mass effect, compressing surrounding brain structures and impairing cerebral perfusion, which can lead to ischemia and further neuronal damage.

• Key complication: Elevated ICP and mass effect increase the risk of brain herniation, a life-threatening condition where brain tissue is displaced across structures within the skull, potentially leading to coma or death if not promptly managed.

Patient Profile

Demographics:

45-year-old male, construction worker

History:

• Key past medical history: Arteriovenous malformation (AVM), hypertension, previous transient ischemic attack (TIA)

• Current medications: Lisinopril, aspirin, atorvastatin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Sudden onset severe headache and loss of consciousness

• Key symptoms: Hemiparesis on the right side, slurred speech, nausea, vomiting, altered mental status

• Vital signs: Blood pressure 210/130 mmHg, heart rate 48 bpm, respiratory rate 8 breaths per minute, temperature 37.8°C, oxygen saturation 82% on room air

Section 1

As the healthcare team swiftly initiates management for the patient, the initial assessment reveals concerning findings. Neurological evaluation shows a Glasgow Coma Scale (GCS) score of 6, indicating severe impairment of consciousness. Pupillary examination reveals anisocoria, with the left pupil dilated and sluggishly reactive to light, suggesting possible transtentorial herniation. Breath sounds are diminished, and the patient is exhibiting Cheyne-Stokes respiration, indicative of brainstem involvement due to increased intracranial pressure. These findings necessitate immediate intervention to stabilize the patient and prevent further neurological deterioration.

A computed tomography (CT) scan of the brain is urgently performed, confirming a large left-sided intracerebral hemorrhage with midline shift and surrounding edema. The presence of blood in the ventricles suggests intraventricular hemorrhage, complicating the clinical picture and increasing the risk of acute hydrocephalus. Blood work reveals severe metabolic acidosis with a pH of 7.25, likely secondary to hypoventilation and tissue hypoxia. Additionally, the patient shows signs of coagulopathy, with an elevated international normalized ratio (INR) of 2.5, possibly exacerbated by aspirin use.

In response to these findings, the team initiates aggressive management. The patient is intubated and mechanically ventilated to secure the airway and optimize oxygenation. Intravenous mannitol is administered to reduce cerebral edema, and emergent neurosurgical consultation is sought to evaluate the need for decompressive craniectomy. Concurrently, fresh frozen plasma is administered to correct the coagulopathy, and antihypertensive therapy is titrated to lower the dangerously elevated blood pressure without compromising cerebral perfusion. Despite these interventions, the patient remains at high risk for further complications, necessitating vigilant monitoring and frequent reassessment to adapt the management plan as needed.

Section 2

As the healthcare team continues to manage the patient's critical condition, a sudden change in status prompts immediate attention. Approximately two hours post-intervention, the patient's neurological status deteriorates further. The nurse notes a decrease in the Glasgow Coma Scale (GCS) score to 4, with only a flexor response to painful stimuli and no verbal response. Additionally, the patient's pupils become fixed and dilated bilaterally, indicating potential worsening of intracranial pressure and herniation. Vital signs are alarming, with the blood pressure spiking to 210/110 mmHg and heart rate dropping to 40 beats per minute, suggestive of Cushing's triad, a classic sign of increased intracranial pressure. The patient's oxygen saturation remains critically low despite mechanical ventilation, dropping to 85%, indicating potential respiratory compromise.

New diagnostic results from repeat imaging reveal that the midline shift has increased, and there is now evidence of additional hemorrhagic expansion with further ventricular involvement. The CT scan also shows early signs of acute hydrocephalus, with significant ventricular enlargement compared to the initial scan. Lab results indicate worsening metabolic acidosis with a pH now at 7.20 and elevated lactate levels at 5.5 mmol/L, reflective of ongoing anaerobic metabolism and poor tissue perfusion. Coagulation profiles show minimal improvement despite plasma administration, with an INR still elevated at 2.3, complicating potential surgical interventions.

In response to these developments, the healthcare team must exercise advanced clinical judgment. The neurosurgeon recommends an emergent external ventricular drain (EVD) placement to relieve hydrocephalus and monitor intracranial pressure. There is also consideration for potential surgical decompression to address the expanding hematoma. The critical care team accelerates the titration of antihypertensive medications to manage the refractory hypertension while balancing cerebral perfusion needs. Additionally, the team contemplates the use of hypertonic saline as an adjunct to mannitol for aggressive osmotherapy. As the patient's condition remains precarious, the team prepares for the possibility of multi-organ support, including renal replacement therapy, should acute kidney injury develop secondary to sustained hypoperfusion. The unfolding complexity of this case underscores the necessity for dynamic and coordinated efforts to optimize patient outcomes.

Section 3

As the team implements the emergent interventions, the initial response to the external ventricular drain (EVD) placement is cautiously optimistic. The immediate reduction in intracranial pressure (ICP) is evident, with the device recording an initial pressure drop from 35 mmHg to 20 mmHg. However, the patient's clinical status remains tenuous. While the ICP reduction provides some relief, the patient's neurological examination shows minimal improvement, with the GCS score remaining at 5, indicating persistent severe brain injury. The pupils remain fixed and dilated, and the patient's response to painful stimuli is still limited to flexion.

The critical care team intensifies their focus on managing the patient's hemodynamic instability. Despite aggressive titration of antihypertensive medication, the blood pressure remains labile, fluctuating between hypertensive crises and periods of relative hypotension, posing a challenge to maintaining adequate cerebral perfusion pressure. The heart rate continues to exhibit bradycardia, oscillating between 35 and 45 beats per minute, necessitating the potential consideration of temporary pacing if the symptomatic bradycardia persists. Meanwhile, the patient's oxygenation status shows slight improvement with oxygen saturation climbing to 88% following adjustments to ventilator settings, yet this remains a critical concern.

Despite these interventions, new complications arise. The patient's metabolic acidosis deepens, with the latest arterial blood gas analysis revealing a pH of 7.15 and lactate levels increasing to 6.2 mmol/L, suggesting worsening tissue hypoxia. The team initiates sodium bicarbonate therapy cautiously, aware of the delicate balance required to avoid exacerbating cerebral edema. Furthermore, early renal function markers indicate a downtrend, with creatinine levels rising to 2.1 mg/dL, prompting early discussions about renal replacement therapy. As the patient's condition evolves, the team remains vigilant, continually reassessing and adapting their strategies to address the multifaceted challenges of this complex case.

Section 4

As the critical care team continues to navigate the complexities of the patient's condition, new diagnostic results provide additional insights into the underlying issues. A repeat CT scan of the brain reveals an increase in the size of the intraparenchymal hemorrhage, suggesting ongoing bleeding or rebleeding from the arteriovenous malformation (AVM). This development is concerning as it may explain the lack of neurological improvement despite the reduction in intracranial pressure. The imaging also shows midline shift progression, which correlates with the patient's unchanging Glasgow Coma Scale (GCS) score and persistent pupillary abnormalities.

In addition to the neurological challenges, the latest laboratory results indicate worsening coagulopathy, with the international normalized ratio (INR) rising to 2.5 and activated partial thromboplastin time (aPTT) significantly prolonged. These findings suggest a potential disseminated intravascular coagulation (DIC) process, possibly triggered by the ongoing cerebral insult and systemic stress response. The hematology consult recommends initiating fresh frozen plasma and cryoprecipitate transfusions to correct the coagulopathy while carefully monitoring for potential volume overload, especially given the patient's fluctuating hemodynamics and emerging renal impairment.

The team faces a critical juncture, requiring advanced clinical reasoning to manage the delicate balance between controlling intracranial pressure, optimizing cerebral perfusion, and addressing the systemic complications. The potential need for surgical intervention to control the hemorrhage must be weighed against the risks of further destabilizing the patient. As the situation evolves, the focus remains on vigilant monitoring and timely adjustments to the treatment plan, with an interdisciplinary approach essential to navigating the multifaceted challenges of this complex case.

Section 5

As the critical care team continues to monitor the patient closely, a notable change in patient status emerges, necessitating immediate clinical intervention. Overnight, the patient's blood pressure becomes increasingly labile, with systolic pressures ranging from 90 to 180 mmHg, indicating potential cerebral autoregulation failure. Concurrently, the heart rate fluctuates between bradycardia and tachycardia, further complicating the hemodynamic management. These swings in vital signs correlate with episodes of desaturation, with oxygen saturation levels occasionally dipping below 88%, prompting concerns about systemic oxygen delivery and cerebral perfusion.

The patient's neurological status remains precarious, with the Glasgow Coma Scale score showing no improvement, staying at a concerning 6. Pupillary assessment continues to reveal anisocoria, with the left pupil remaining fixed and dilated. In light of these findings and the progression of midline shift noted on imaging, the neurosurgery team is consulted to evaluate the feasibility and timing of surgical intervention. However, with the patient's coagulopathy and renal impairment, the risk of perioperative complications looms large, requiring careful deliberation.

Additionally, the patient's renal function further declines, with the latest laboratory results showing a creatinine level of 2.8 mg/dL and a blood urea nitrogen (BUN) of 48 mg/dL, suggestive of acute kidney injury secondary to the systemic inflammatory response. This renal impairment complicates fluid management, necessitating a delicate balance to prevent exacerbation of cerebral edema while avoiding fluid overload. As the critical care team collaborates with nephrology and hematology specialists, the decision is made to start renal replacement therapy to manage fluid status and electrolyte imbalances, while continuing coagulation support. This multifaceted approach highlights the complexity of the situation, requiring ongoing reassessment and adaptation of the treatment strategy to navigate the intricate interplay of systemic and neurological challenges.